On 3 November 2021, the Technical Advisory Group for Emergency Use Listing listed the Bharat Biotech BBV152 COVAXIN vaccine against COVID-19 for emergency use.
The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim policy recommendations for the use of the Bharat Biotech BBV152 COVAXIN vaccine.
This article provides a summary of those interim recommendations.The background document is also available here. Who should be vaccinated first?Where COVID-19 vaccine supplies are limited, priority should go to health workers at high risk of exposure and older people.Countries can refer to the WHO Prioritization Roadmap and the WHO Values Framework for guidance.The vaccine is not recommended for people younger than 18